Home › Cancro del polmone non a piccole cellule › Ohio › Toledo
Studi clinici su Cancro del polmone non a piccole cellule a Toledo, OH
17 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Toledo e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · a 8 mi di distanza
- ProMedica Flower Hospital, Sylvania · a 9 mi di distanza
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
In reclutamentoFase 3
- ProMedica Flower Hospital, Sylvania · a 9 mi di distanza
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
In reclutamentoFase 1
- Site 06, Maumee · a 9 mi di distanza
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
In reclutamentoFase 3
- Taylor Cancer Research Center, Maumee · a 9 mi di distanza
Pan-tumor MRD Study
In reclutamentoStudio osservazionale
- Taylor Cancer Research Center, Maumee · a 9 mi di distanza
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
In reclutamentoFase 3
- Research Site, Toledo
- Research Site, Maumee · a 9 mi di distanza
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2
- Mercy Health - Perrysburg Cancer Center /ID# 270536, Perrysburg · a 8 mi di distanza
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
In reclutamentoStudio osservazionale
- Toledo Clinic Cancer Center, Toledo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · a 8 mi di distanza
- ProMedica Flower Hospital, Sylvania · a 9 mi di distanza
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
In reclutamentoFase 1/2
- Taylor Cancer Research Center, Maumee · a 9 mi di distanza
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- Research Site, Maumee · a 9 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- ProMedica Flower Hospital, Sylvania · a 9 mi di distanza
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2
- ProMedica Flower Hospital, Sylvania · a 9 mi di distanza
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- ProMedica Flower Hospital, Sylvania · a 9 mi di distanza
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Taylor Cancer Research Center, Maumee · a 9 mi di distanza
GEMINI-NSCLC: NSCLC Biomarker Study
In reclutamentoStudio osservazionale
- Taylor Cancer Research Center, Maumee · a 9 mi di distanza
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
In reclutamentoFase 1/2
- Taylor Cancer Research Center (site 204), Maumee · a 9 mi di distanza
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY120 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH56 studi
- Washington, DC55 studi
Altri studi a Toledo
- Cancro ovarico12 studi
- Cancro ai polmoni11 studi
- Cancro metastatico10 studi
- Ictus9 studi
- Cancro dell'endometrio8 studi
- Melanoma8 studi
- Cancro pancreatico8 studi
- Carcinoma a cellule squamose della testa e del collo8 studi
- Cancro dell'esofago7 studi
- Cancro alla prostata7 studi
- Insufficienza cardiaca7 studi
- Cancro colorettale7 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.